CVSCX
Price
$16.56
Change
+$0.01 (+0.06%)
Updated
Aug 21 closing price
Net Assets
18.6B
WMNAX
Price
$10.47
Change
-$0.00 (-0.00%)
Updated
Aug 21 closing price
Net Assets
184.5M
Interact to see
Advertisement

CVSCX vs WMNAX

CVSCX vs WMNAX Comparison Chart in %
View a ticker or compare two or three
VS
CVSCX vs. WMNAX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVSCX is a StrongBuy and WMNAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CVSCX has more cash in the bank: 18.6B vs. WMNAX (184M). WMNAX pays higher dividends than CVSCX: WMNAX (1.56) vs CVSCX (0.78). CVSCX was incepted earlier than WMNAX: CVSCX (27 years) vs WMNAX (6 years). CVSCX (2.01) is less costly to investors than WMNAX (1.21). WMNAX is a more actively managed with annual turnover of: 89.00 vs. CVSCX (43.00). WMNAX has a lower initial minimum investment than CVSCX: WMNAX (1000) vs CVSCX (2500). WMNAX annual gain was more profitable for investors over the last year : 6.92 vs. CVSCX (5.66). WMNAX return over 5 years is better than : 24.15 vs. CVSCX (16.46).
CVSCXWMNAXCVSCX / WMNAX
Total Expense Ratio2.011.01199%
Annual Report Gross Expense Ratio2.011.21166%
Fund Existence27 years6 years-
Gain YTD3.5224.10086%
Front LoadN/A3%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets18.6B184M10,109%
Annual Yield % from dividends0.781.5650%
Returns for 1 year5.666.9282%
Returns for 3 years15.2223.0466%
Returns for 5 years16.4624.1568%
Returns for 10 years30.77N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSVAX15.940.09
+0.57%
Columbia Sm Cp Val and Inflection Inst
KCEIX13.980.06
+0.43%
Knights of Columbus Long/Short Eq I
MLRSX12.110.05
+0.41%
NYLI Winslow Large Cap Growth Class R6
VMIDX26.49N/A
N/A
VALIC Company I Mid Cap Index
MEYWX10.90N/A
N/A
Manning & Napier Equity Series W